NATURE’S SUNSHINE PRODUCTS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2018-03-16
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2017 was 0.00%, a 100.00% decline from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2016 was 0.60%.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2015 was 0.00%.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2014 was 0.00%, a 100.00% decline from fiscal 2013.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2017-12-31 | 0.00% 10-K · filed 2018-03-16 | |
| 2016-12-31 | 0.60% 10-K · filed 2018-03-16 | |
| 2015-12-31 | 0.00% 10-K · filed 2018-03-16 | 3.40% 10-K · filed 2016-03-14 |
| 2014-12-31 | 0.00% 10-K · filed 2017-03-14 | -2.70% 10-K · filed 2015-03-13 |
| 2013-12-31 | 1.40% 10-K · filed 2016-03-14 | -1.10% 10-K · filed 2014-03-17 |
| 2012-12-31 | -2.10% 10-K · filed 2015-03-13 | -1.50% 10-K · filed 2013-03-07 |
| 2011-12-31 | -0.90% 10-K · filed 2014-03-17 | 0.50% 10-K · filed 2013-03-07 |
| 2010-12-31 | -2.00% 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |